Ginkgo Bioworks Holdings Inc vs Jabil Inc — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M), while Jabil Inc trades at $360.5 (market cap $37.37B). The key difference: Jabil Inc is far larger — about 73.9× Ginkgo Bioworks Holdings Inc's market cap, and Jabil Inc pays a 0.09% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.
| DNA | JBL | |
|---|---|---|
Market Cap | $505.73M | $37.37B |
Sector | Health | Technology |
52-Week High | $16.14 | $385.50 |
52-Week Low | $5.48 | $192.49 |
Enterprise Value | $607.68M | $39.90B |
Dividend Yield | — | 0.09% |
Trailing returns across standard periods
Latest headlines on both assets
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →Jabil is a global manufacturing solutions provider for industries including healthcare, automotive, and cloud. It offers comprehensive design, engineering, and supply chain management for complex electronic products.
Read more on JBL →